Biopharma's stock market winners of 2022 revealed

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

4D Pharma reveals progress in phase 2 trial of live biotherapeutic

Prestige Biopharma aims to become leading cancer drug developer

CTI BioPharma Presents New Anemia Benefit Data from Pacritinib

Stock Market Activity

Evaluate Search

The top 10 biopharma M&A deals of 2022

How Will the Stock Market Do in 2022? Expect a Tough Year but Lots

COVID-19 major influence on Biopharma Index in 2021

Global pharma stocks struggle in the third quarter

CureVac Evaluate

Evaluate Search

VC funding trends in biotechnology

Top 20 Drugs in 2023 by 2022 Sales Statistics - Xtalks

Rhythm Pharmaceuticals

Evaluate Search